文献速递前列腺癌

腹膜间置瓣与机器人辅助腹腔镜根治性前列腺切除术后盆腔淋巴结清扫相关淋巴囊肿形成的关联:系统评价与Meta分析

The Association of a Peritoneal Interposition Flap With Lymphocele Formation After Pelvic Lymph Node Dissection During Robotic-assisted Laparoscopic Radical Prostatectomy: A Systematic Review and Meta-analysis.
PubMed 文献 · Urology · 2024-02-16

该系统评价与Meta分析纳入5项随机对照试验和4项观察性研究共2941例患者,评估腹膜间置瓣(PIF)与机器人辅助腹腔镜根治性前列腺切除(RALP)联合盆腔淋巴结清扫术后淋巴囊肿形成的关联。仅分析随机对照试验时,PIF与90天症状性淋巴囊肿风险降低相关(合并OR 0.44,95%CI 0.28-0.69;I²=3%);随机对照试验与观察性研究合并分析亦显示风险降低(OR 0.35,95%CI 0.22-0.56;I²=17%)。PIF与90天任何淋巴囊肿风险降低相关(OR 0.40,95%CI 0.28-0.56;I²=39%),两组术后并发症无统计学显著差异(OR 0.89;95%CI 0.69-1.14;I²=20%)。

要点

  • PIF与RALP联合盆腔淋巴结清扫术后90天症状性淋巴囊肿风险降低相关,仅RCT合并OR 0.44(95%CI 0.28-0.69)。
  • PIF与90天任何淋巴囊肿风险降低相关,合并OR 0.40(95%CI 0.28-0.56)。
  • PIF与术后并发症无统计学显著差异,合并OR 0.89(95%CI 0.69-1.14)。

核心结论

  • 使用PIF与术后90天内症状性和任何淋巴囊肿形成风险降低约50%相关,且与术后并发症增加无关。

研究设计与样本

  • 系统评价与Meta分析,检索MEDLINE、Embase、Web of Science和Cochrane Central Register of Controlled Trials截至2023年8月30日,纳入比较RALP联合盆腔淋巴结清扫伴或不伴PIF的随机和非随机研究。
  • 共纳入5项随机对照试验和4项观察性研究,总计2941例患者,采用随机效应模型进行Meta分析评估PIF与90天术后结局的关联。

主要发现

  • 仅分析随机对照试验时,PIF与90天症状性淋巴囊肿风险降低相关(合并OR 0.44,95%CI 0.28-0.69;I²=3%)。
  • 随机对照试验与观察性研究合并分析时,PIF与90天症状性淋巴囊肿风险降低相关(OR 0.35,95%CI 0.22-0.56;I²=17%)。
  • PIF与90天任何淋巴囊肿风险降低相关(OR 0.40,95%CI 0.28-0.56;I²=39%)。
  • 两组术后并发症无统计学显著差异(OR 0.89;95%CI 0.69-1.14;I²=20%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To conduct a systematic review and meta-analysis to evaluate the association of a peritoneal interposition flap (PIF) with lymphocele formation following robotic-assisted laparoscopic radical prostatectomy (RALP) with pelvic lymph node dissection. METHODS: We conducted a systematic search of MEDLINE, Embase, Web of Science, and the Cochrane Central Register of Controlled Trials through August 30, 2023, to identify randomized and nonrandomized studies comparing RALP with pelvic lymph node dissection with and without PIF. A random effects meta-analysis was then performed to evaluate the associations of PIF with 90-day postoperative outcomes. RESULTS: Five randomized controlled trials (RCTs) and four observational studies, including a total of 2941 patients, were included. The use of PIF was associated with a reduced risk of 90-day symptomatic lymphocele formation after RALP when examining only RCTs (pooled odds ratios [OR] 0.44, 95% CI 0.28-0.69; I2 =3%) and both RCTs and observational studies (OR 0.35, 95% CI 0.22-0.56; I2 =17%). Similarly, use of PIF was associated with a reduced risk of 90-day any lymphocele formation (OR 0.40, 95% CI 0.28-0.56, I2 =39%). There were no statistically significant differences in postoperative complications between the two groups (OR 0.89; 95% CI 0.69-1.14; I2 =20%). CONCLUSION: Use of the PIF is associated with an approximately 50% reduced risk of symptomatic and any lymphocele formation within 90-days of surgery, and it is not associated with an increase in postoperative complications.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Estevez A, Bansal UK, Wagner JR, et al. The Association of a Peritoneal Interposition Flap With Lymphocele Formation After Pelvic Lymph Node Dissection During Robotic-assisted Laparoscopic Radical Prostatectomy: A Systematic Review and Meta-analysis. Urology. 2024. PMID: 38369197. doi:10.1016/j.urology.2024.01.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。